A Validation Study for Recurrence Risk Stratification of Stage II Colon Cancer Using the 55-Gene Classifier.

CONCLUSIONS: We conclude that the 55GC is a useful and reproducible grading system for stage II CC recurrence risk stratification.
PMID: 32235113 [PubMed - as supplied by publisher]

Source: Oncology - March 31, 2020 Category: Cancer & Oncology Authors: Shinto E, Oki E, Shimokawa M, Yamaguchi S, Ishiguro M, Morita M, Kusumoto T, Tomita N, Hashiguchi Y, Tanaka M, Ohnuma S, Tada S, Matsushima T, Hase K Tags: Oncology Source Type: research